» Articles » PMID: 22014266

Ligusticum Chuanxiong Hort: a Review of Chemistry and Pharmacology

Overview
Journal Pharm Biol
Specialties Pharmacology
Pharmacy
Date 2011 Oct 22
PMID 22014266
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Ligusticum chuanxiong Hort (LC; Umbelliferae) is an effective medical plant, which has been extensively applied for many years to treat various diseases with other Chinese herbal medicines. Although a considerable amount of scientific research was reported on LC in the last decade, it is currently scattered across various publications. The present review comprises the chemical and pharmacological research on LC in the last decade.

Objective: The objective of this review is to bring together most of the scientific research available on LC and evaluate its effects and mechanisms.

Methods: The information for 82 cases included in this review was compiled using major databases such as Medline, Elsevier, Springer, Pubmed, and Scholar.

Results: The compounds contained in LC can be divided into five kinds, essential oil (EO), alkaloids, phenolic acids, phthalide lactones, and other constituents. A great deal of pharmacological research has been done, which mainly focuses on cardiovascular and cerebrovascular effects, antioxidation, neuroprotection, antifibrosis, antinociception, antiinflammation, and antineoplastic activity.

Conclusion: A large number of pharmacological and chemical studies during the last 10 years have demonstrated the vast medicinal potential of LC. It is still very clear that LC is a plant with widespread use now and also with extraordinary potential for the future. The documents strongly support the view that LC has beneficial therapeutic properties and indicates its potential as an effective adaptogenic herbal remedy.

Citing Articles

Levistolide a Attenuates Acute Kidney Injury in Mice by Inhibiting the TLR-4/NF-κB Pathway.

Shi J, Li S, Yi L, Gao M, Cai J, Yang C Drug Des Devel Ther. 2024; 18:5583-5597.

PMID: 39654604 PMC: 11625643. DOI: 10.2147/DDDT.S476548.


Combining single-cell RNA sequencing and network pharmacology to explore the target of cangfu daotan decoction in the treatment of obese polycystic ovary syndrome from an immune perspective.

Liu D, Wei C, Guan L, Ju W, Xiang S, Lian F Front Pharmacol. 2024; 15:1451300.

PMID: 39539629 PMC: 11557475. DOI: 10.3389/fphar.2024.1451300.


Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies.

Zhang Y, Liu E, Gao H, He Q, Chen A, Pang Y Heliyon. 2024; 10(17):e37059.

PMID: 39296083 PMC: 11408005. DOI: 10.1016/j.heliyon.2024.e37059.


Combining Network Pharmacology and Transcriptomics to Investigate the Mechanisms of Yujiang Paidu Decoction in the Treatment of Chronic Rhinosinusitis with Nasal Polyps.

Li Y, Yin Y, Xiong J, Zhang Z, Li L, Zhang B Drug Des Devel Ther. 2024; 18:3791-3809.

PMID: 39219695 PMC: 11365509. DOI: 10.2147/DDDT.S461769.


Mechanism and therapeutic potential of traditional Chinese medicine extracts in sepsis.

Fu C, Li J, Chen J, Liang H, Zhao W, He S Front Pharmacol. 2024; 15:1365639.

PMID: 39021837 PMC: 11251979. DOI: 10.3389/fphar.2024.1365639.